10x Genomics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
31 août 2021 16h05 HE
|
10x Genomics, Inc.
PLEASANTON, Calif., Aug. 31, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the Morgan Stanley 19th Annual Global Healthcare...
10x Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit
06 août 2021 08h00 HE
|
10x Genomics, Inc.
PLEASANTON, Calif., Aug. 06, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming UBS Genomics 2.0 and MedTech Innovations...
10x Genomics Reports Second Quarter 2021 Financial Results
04 août 2021 16h05 HE
|
10x Genomics, Inc.
PLEASANTON, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the second quarter ended June 30, 2021. Recent Highlights Revenue was...
10x Genomics Signs Global Patent Cross License Agreement with Bio-Rad
27 juil. 2021 06h30 HE
|
10x Genomics, Inc.
Agreement to Cross License Single Cell Technologies Ends all Ongoing Legal Disputes PLEASANTON, Calif., July 27, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today announced that it...
10x Genomics Introduces New Chromium X Series for Single Cell Analysis
14 juil. 2021 08h00 HE
|
10x Genomics, Inc.
PLEASANTON, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Building on its industry leading position in single cell analysis, 10x Genomics (NASDAQ: TXG) today announced commercial availability of its new...
10x Genomics to Report Second Quarter Financial Results on August 4, 2021
07 juil. 2021 16h03 HE
|
10x Genomics, Inc.
PLEASANTON, Calif., July 07, 2021 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the second quarter 2021 after market close on Wednesday, August...
10x Genomics Unlocks Whole Transcriptome Analysis in FFPE Tissues With New Visium Assay, Now Shipping
10 juin 2021 08h00 HE
|
10x Genomics, Inc.
PLEASANTON, Calif., June 10, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today announced it is shipping its new Visium Spatial Gene Expression for FFPE (formalin-fixed and...
10x Genomics to Participate in Upcoming June Investor Conferences
24 mai 2021 08h00 HE
|
10x Genomics, Inc.
PLEASANTON, Calif., May 24, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating virtually in the following investor conferences: William...
10x Genomics Reports First Quarter 2021 Financial Results
05 mai 2021 16h03 HE
|
10x Genomics, Inc.
PLEASANTON, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the first quarter ended March 31, 2021. Recent Highlights Revenue was...
10x Genomics to Present at the BofA Securities 2021 Virtual Healthcare Conference
29 avr. 2021 16h05 HE
|
10x Genomics, Inc.
PLEASANTON, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming BofA Securities 2021 Virtual Healthcare...